BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17897003)

  • 1. The pharmaceutical potential of histone deacetylase inhibitors.
    Elaut G; Rogiers V; Vanhaecke T
    Curr Pharm Des; 2007; 13(25):2584-620. PubMed ID: 17897003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors: overview and perspectives.
    Dokmanovic M; Clarke C; Marks PA
    Mol Cancer Res; 2007 Oct; 5(10):981-9. PubMed ID: 17951399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors.
    Marks PA; Richon VM; Miller T; Kelly WK
    Adv Cancer Res; 2004; 91():137-68. PubMed ID: 15327890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC inhibitors for the treatment of cancer.
    Secrist JP; Zhou X; Richon VM
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1422-7. PubMed ID: 14763127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects: histone deacetylase inhibitors.
    Dokmanovic M; Marks PA
    J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assay for inhibitory activity of histone deacetylase].
    Yoshida M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endometrial cytodifferentiation by histone deacetylase inhibitors.
    Uchida H; Maruyama T; Nagashima T; Ono M; Masuda H; Arase T; Sugiura I; Onouchi M; Kajitani T; Asada H; Yoshimura Y
    Hum Cell; 2006 Feb; 19(1):38-42. PubMed ID: 16643606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases.
    Echaniz-Laguna A; Bousiges O; Loeffler JP; Boutillier AL
    Curr Med Chem; 2008; 15(13):1263-73. PubMed ID: 18537606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
    Yoshida M; Shimazu T; Matsuyama A
    Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histone-deacetylases inhibitors: from TSA to SAHA].
    Peixoto P; Lansiaux A
    Bull Cancer; 2006 Jan; 93(1):27-36. PubMed ID: 16455503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of histone deacetylase inhibitors for cancer treatment.
    Marchion D; Münster P
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
    Frew AJ; Johnstone RW; Bolden JE
    Cancer Lett; 2009 Aug; 280(2):125-33. PubMed ID: 19359091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors: gathering pace.
    Carey N; La Thangue NB
    Curr Opin Pharmacol; 2006 Aug; 6(4):369-75. PubMed ID: 16781195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Histone Deacetylases in Diseases: Where Are We?
    Benedetti R; Conte M; Altucci L
    Antioxid Redox Signal; 2015 Jul; 23(1):99-126. PubMed ID: 24382114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histone deacetylase inhibitors in the treatment of cancer (Review).
    Mei S; Ho AD; Mahlknecht U
    Int J Oncol; 2004 Dec; 25(6):1509-19. PubMed ID: 15547685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical origins of isoform selectivity in histone deacetylase inhibitors.
    Butler KV; Kozikowski AP
    Curr Pharm Des; 2008; 14(6):505-28. PubMed ID: 18336297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activities of histone deacetylase inhibitors.
    Bolden JE; Peart MJ; Johnstone RW
    Nat Rev Drug Discov; 2006 Sep; 5(9):769-84. PubMed ID: 16955068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases.
    Wang Y; Stowe RL; Pinello CE; Tian G; Madoux F; Li D; Zhao LY; Li JL; Wang Y; Wang Y; Ma H; Hodder P; Roush WR; Liao D
    Chem Biol; 2015 Feb; 22(2):273-84. PubMed ID: 25699604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.